Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.2 GBX | -1.15% | +6.59% | +9.60% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
05-03 | Wall Street rises thanks to good and bad economic news |
Sales 2024 * | 514M 641M 51.35B | Sales 2025 * | 535M 668M 53.5B | Capitalization | 649M 809M 64.86B |
---|---|---|---|---|---|
Net income 2024 * | 36M 44.93M 3.6B | Net income 2025 * | 44M 54.91M 4.4B | EV / Sales 2024 * | 1.45 x |
Net Debt 2024 * | 95.61M 119M 9.56B | Net Debt 2025 * | 61.12M 76.27M 6.11B | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
15.1
x | Employees | 6,165 |
Yield 2024 * |
2.38% | Yield 2025 * |
2.79% | Free-Float | 98.17% |
1 day | +0.64% | ||
1 week | +11.03% | ||
Current month | +21.14% | ||
1 month | +20.03% | ||
3 months | +12.30% | ||
6 months | +23.82% | ||
Current year | +10.88% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Egan
CEO | Chief Executive Officer | 52 | 31/12/97 |
Yvonne Monaghan
DFI | Director of Finance/CFO | 66 | 30/06/84 |
Steve McKeever
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 28/08/18 | |
Jock Lennox
CHM | Chairman | 67 | 30/06/16 |
Yvonne Monaghan
DFI | Director of Finance/CFO | 66 | 30/06/84 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
09/05/24 | 155.2 | -1.15% | 472 958 |
08/05/24 | 157 | +0.64% | 564,209 |
07/05/24 | 156 | +4.42% | 648,632 |
03/05/24 | 149.4 | +2.61% | 1,034,595 |
02/05/24 | 145.6 | +2.97% | 1,243,281 |
Delayed Quote London S.E., May 08, 2024 at 04:35 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.88% | 810M | |
-2.04% | 1.73B | |
-20.12% | 219M | |
-28.09% | 196M | |
+1.87% | 176M | |
+124.57% | 123M | |
+38.06% | 122M | |
+28.75% | 107M |
- Stock Market
- Equities
- JSG Stock